← Back
$ADPT All transactions

Adaptive Biotechnologies Corp

▼ SELL

$ Value

$17K

Shares

1,929

Price

$9

Filed

May 20

Insider

Name

PISKEL KYLE

Title

Chief Financial Officer

CIK

0001780662

Roles

Officer

Transaction Details

Transaction Date

2025-05-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

269,581

Footnotes

This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0001062993-25-009904

Form Type

4/A

Issuer CIK

0001478320

PISKEL KYLE's History

Date Ticker Type Value
2026-03-11 ADPT $246K
2026-03-04 ADPT A $0
2026-02-04 ADPT M $26K
2026-02-04 ADPT $40K
2026-02-04 ADPT M $0
2026-01-12 ADPT M $52K
2026-01-12 ADPT $77K
2026-01-12 ADPT M $0
2025-11-28 ADPT M $78K
2025-11-28 ADPT M $29K

Other Insiders at ADPT (90d)

Insider Bought Sold Last
GRIFFIN MICHELLE RENEE $949K 2026-03-11
NEUPERT PETER M 2026-03-04
HERSHBERG ROBERT 2026-03-04
ROBINS CHAD M
CEO and Chairman
$18.6M 2026-04-08
LO FRANCIS
Chief People Officer
$1.3M 2026-04-08
PISKEL KYLE
Chief Financial Officer
$286K 2026-03-11
RUBINSTEIN JULIE
President and COO
$12.3M 2026-04-21
ROBINS HARLAN S
Chief Scientific Officer
$7.5M 2026-04-08
BENZENO SHARON
Chief Commercial Ofc Imm Med
$831K 2026-03-11
BOBULSKY SUSAN
Chief Commercial Officer, MRD
$544K 2026-03-11
OWEN KATEY EINTERZ 2026-03-04